Bio-Implants Market Report 2026

Bio-Implants Market Overview

• Bio-Implants market size has reached to $136.96 billion in 2025 • Expected to grow to $228.53 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Rising Prevalence Of Chronic Conditions Boosts Growth In The Bio-Implant Market • Market Trend: New Implant To Advance The Standard Of Care For Patients • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bio-Implants Market?

Bio-implants are prosthesis or artificial medical devices that replace missing tissues and supports a damaged biological structure to improve biological functions of the body and are made up of material obtained of human or animal origin or biosynthetic materials. The bio-implants are used to assist and regularize human physiological functions. The main types of bio-implants are cardiovascular implants, dental implants, spinal bio-implants, orthopedic implants, ophthalmic implants, and other types. The cardiovascular implants are used in heart valves and coronary stents for the treatment of cardiac complications. Cardiovascular implants are designed to stay in a patient's body to maintain healthy blood arteries and a beating heart. The bio-implants are made of various materials including metallic, ceramic, polymer, and biological. The bio-implants have different origins such as allograft, autograft, xenograft, and synthetic. The bio-implants are used by ambulatory surgical centers, clinics, hospital, and other end-users.

What Is The Bio-Implants Market Growth Forecast?

The bio-implants market size is expected to see rapid growth in the next few years. It will grow to $228.53 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing investments in regenerative medicine, rising adoption of 3d-printed implants, growing focus on personalized healthcare solutions, expansion of outpatient surgical procedures, increasing demand for next-generation bio-implants. Major trends in the forecast period include increasing adoption of bio-compatible implant materials, rising demand for customized and patient-specific implants, growing use of minimally invasive implant procedures, expansion of regenerative and tissue-engineered implants, enhanced focus on long-term implant durability.

Global Bio-Implants Market Segmentation

1) By Type: Cardiovascular Implants, Dental Implants, Spinal Bio-Implants, Orthopedic Implants, Ophthalmic Implants, Other Types 2) By Material: Metallic, Ceramic, Polymer, Biological 3) By Origin: Allograft, Autograft, Xenograft, Synthetic 4) By End-User: Ambulatory Surgical Centers, Clinics, Hospital, Other End-Users Subsegments: 1) By Cardiovascular Implants: Stents, Heart Valves, Pacemakers 2) By Dental Implants: Endosteal Implants, Subperiosteal Implants, Zygomatic Implants 3) By Spinal Bio-Implants: Spinal Fusion Devices, Intervertebral Discs, Spinal Rods And Plates 4) By Orthopedic Implants: Joint Replacement Implants, Fracture Fixation Devices, Bone Plates And Screws 5) By Ophthalmic Implants: Intraocular Lenses (IOLs), Retinal Implants, Corneal Implants 6) By Other Types: Cochlear Implants, Tissue Engineering Implants, Biomaterial Scaffolds

What Is The Driver Of The Bio-Implants Market?

The increasing prevalence of chronic conditions is expected to drive the bio-implant market going forward. Chronic conditions such as cardiovascular diseases and arthritis refer to medical conditions that persist for a year or longer, require continuous medical care, and restrict everyday activities. The bio-implants are used in managing and monitoring chronic conditions by reducing the mortality rate caused by chronic diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic conditions is fueling the growth of the bio-implant industry.

Key Players In The Global Bio-Implants Market

Major companies operating in the bio-implants market are Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Johnson & Johnson, Arthrex Inc., Boston Scientific Corporation, Smith & Nephew PLC, B. Braun Melsungen AG, Straumann Holding AG, Organogenesis Holdings Inc., Exactech Inc., Edwards Lifesciences Corporation, Biotronik SE & Co. KG, aap Implantate AG, Abbott Laboratories, Cook Medical LLC, Globus Medical Inc., Integra LifeSciences Holdings Corporation, LivaNova PLC, MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., Terumo Corporation

Global Bio-Implants Market Trends and Insights

Major companies operating in the bio-implants market are launching new Implants, such as the REGENETEN Bioinductive Implants, to advance the standard of care for patients. The REGENETEN Bioinductive Implant is a collagen-based solution that supports the body's natural healing response by facilitating the growth of new tendon-like tissue. For instance, in July 2023, Smith+Nephew, a UK-based medical technology company, launched its REGENETEN Bioinductive Implant in India, with over 100,000 global procedures completed since its introduction. This collagen-based implant supports the body's natural healing response, promoting the growth of new tendon-like tissue to augment existing tendons. Delivered arthroscopically, this implant was the size of a postage stamp which became invisible in six months, replaced by new tendon-like tissue. This implant has demonstrated positive results in rotator cuff disease, with a recent trial showing an 86% relative reduction in re-tear rates at 12 months compared to conventional surgery alone.

What Are Latest Mergers And Acquisitions In The Bio-Implants Market?

In January 2024, Enovis Corporation, a US-based healthcare technology company, acquired LimaCorporate S.p.A. for an undisclosed amount. With this acquisition, Enovis Corporation aims to expand its global orthopedic portfolio, enhance its product offerings in joint reconstruction and digital solutions, and strengthen its presence in key international markets. LimaCorporate S.p.A. is an Italy-based healthcare technology company that specializes in designing, developing, and manufacturing orthopedic implants, surgical instruments, and digital solutions for joint reconstruction and musculoskeletal care.

Regional Outlook

North America was the largest region in the bio-implants market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Bio-Implants Market?

The bio-implants market consists of sales stents, pacing devices, orthobiologics, trauma implants, sport medicines, thoracolumber implants, interverteberal spacers, machined allograft spacers, and motion preservation implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.